38,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
19 °P sammeln
  • Broschiertes Buch

The book summarizes developments in all areas of urological cancer including clinical and molecular advances. The aim of the book is to educate urologists and oncologists so that they are able to understand scientific developments within urological oncology and be up-to-date with clinical practice in this area. The book includes both guidelines for clinical practice and synopses of advances in science research. This practical handbook provides a distillation of current practice and research for oncologists and urologists in clinical practice. Its author has published eleven books on cancer and is the founder of the "Prostate Cancer Charity". …mehr

Produktbeschreibung
The book summarizes developments in all areas of urological cancer including clinical and molecular advances. The aim of the book is to educate urologists and oncologists so that they are able to understand scientific developments within urological oncology and be up-to-date with clinical practice in this area. The book includes both guidelines for clinical practice and synopses of advances in science research. This practical handbook provides a distillation of current practice and research for oncologists and urologists in clinical practice. Its author has published eleven books on cancer and is the founder of the "Prostate Cancer Charity".
Autorenporträt
Jonathan Waxman is a Professor of Oncology at the Hammersmith Hospital, London. He is a clinician who has helped develop new treatments for cancer, which are now part of standard practice. He is the author of around 350 research papers and chapters, eleven professional books on cancer, a book on medical negligence law, a novel, and a book of short stories which was published by Springer in 2011. He directs a laboratory research group comprising 31 scientists, and founded The Prostate Cancer Charity, the first United Kingdom national organisation promoting research and patient support for this condition. He helped establish an All Party Parliamentary Group to improve cancer treatment and rationalise cancer research throughout the UK, and has developed and led several media campaigns to rationalise cancer treatments and change government health policy.